Squamous cell carcinomas of the head and neck * Commentary: Head and neck carcinomas in the developing world

作者: R J Sanderson

DOI: 10.1136/BMJ.325.7368.822

关键词: OncologyEpidemiologyMedicineHead and neck cancerGeneral surgeryCarcinomaCancerEpidermoid carcinomaPalliative careRadiation therapyPopulationInternal medicineGeneral Medicine

摘要: # Squamous cell carcinomas of the head and neck {#article-title-2} Public awareness this common form cancer needs to be increased because despite important advances in treatment, prognosis still largely depends on stage presentation More than 90% tumours are squamous carcinomas. Cancer neck, which can arise several places, is often preventable, if diagnosed early usually curable. Unfortunately, patients present with advanced disease that incurable or requires aggressive leaves them functionally disabled. We have reviewed current practice potential future referral, diagnosis, management cancer. #### Summary points We gathered information from sources, including personal experience treating a multidisciplinary tertiary referral centre Medline Cochrane databases. Squamous one most cancers worldwide, incidences more 30 per 100 000 population India (oral cancer) France Hong Kong (nasopharyngeal cancer). It constitutes about 4% all United States 5% Kingdom. A total 2940 new cases lip, mouth, pharyngeal men were reported Kingdom 1996: an incidence … Correspondence to: W Wei

参考文章(26)
Wolfgang Oster, Robert L. Capizzi, Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. International Journal of Hematology. ,vol. 72, pp. 425- 435 ,(2000)
Fadlo R. Khuri, John Nemunaitis, Ian Ganly, James Arseneau, Ian F. Tannock, Larry Romel, Martin Gore, Janet Ironside, R.H. MacDougall, Carla Heise, Britta Randlev, Ann M. Gillenwater, Patricia Bruso, Stanley B. Kaye, Waun Ki Hong, David H. Kirn, A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nature Medicine. ,vol. 6, pp. 879- 885 ,(2000) , 10.1038/78638
R. H. Hruban, R. Corio, D. Sidransky, H. Nawroz, P. Van Der Riet, W. Koch, K. Tokino, Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Research. ,vol. 54, pp. 1156- 1158 ,(1994)
F. Caponigro, E. Massa, L. Manzione, G. Rosati, M. Biglietto, L. De Lucia, C. Sguotti, P. Sganga, A. Avallone, P. Comella, G. Mantovani, G. Comella, Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG) Annals of Oncology. ,vol. 12, pp. 199- 202 ,(2001) , 10.1023/A:1008322415335
Kristin Bjordal, Marianne Ahlner-Elmqvist, Eva Hammerlid, Morten Boysen, Jan F. Evensen, Anders Bi??rklund, Magnus Jannert, Thomas Westin, Stein Kaasa, A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope. ,vol. 111, pp. 1440- 1452 ,(2001) , 10.1097/00005537-200108000-00022
Eva Hammerlid, Kristin Bjordal, Marianne Ahlner-Elmqvist, Morten Boysen, Jan F. Evensen, Anders Bi??rklund, Magnus Jannert, Stein Kaasa, Marianne Sullivan, Thomas Westin, A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope. ,vol. 111, pp. 669- 680 ,(2001) , 10.1097/00005537-200104000-00021
George P. Browman, D. Ian Hodson, Robert J. Mackenzie, Nancy Bestic, Lisa Zuraw, , Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 23, pp. 579- 589 ,(2001) , 10.1002/HED.1081
Victor Wünsch-Filho, Esther Archer de Camargo, The burden of mouth cancer in Latin America and the Caribbean: epidemiologic issues. Seminars in Oncology. ,vol. 28, pp. 158- 168 ,(2001) , 10.1016/S0093-7754(01)90087-9